Both in Pharmaceuticals
Oramed Pharmaceuticals vs Zentalis Pharmaceuticals
Over the past year ORMP returned +76.3% and ZNTL returned +20.5%; their daily moves had a correlation of 0.16.
ORMP +76.3% ZNTL +20.5%Growth of $1, one year, split-adjusted
| Metric | ORMP | ZNTL |
|---|---|---|
| Price | $4.13 | $2.03 |
| Market cap | $171.6M | $191.7M |
| Today | −0.84% | +2.27% |
| 1 month | −12.0% | −25.4% |
| 6 months | +7.4% | −48.9% |
| Year to date | +44.7% | +50.0% |
| 1 year | +74.1% | +17.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 1.0× | — |
| Price / sales | — | — |
| Net cash | $50.6M | $174.6M |
| Dividend yield | 6.06% | — |
| Volatility (60d) | 35.8% | 77.0% |
| Short % of float | 4.3% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).